BRCA1 PVs have also been thought to induce aberrant interaction of breast cancer cells with other cell surface and cytoskeletal proteins responsible for the regulation of EMT such as P-cadherin, beta-catenin, vimentin, and cytokeratins [15]. The gene discussed is BRCA1; the disease is breast carcinoma.